ESC Premium Access

Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

Congress Presentation

About the speaker

Doctor Thomas Cuisset

Hospital La Timone of Marseille, Marseille (France)
4 presentations
0 follower

3 more presentations in this session

Innovative strategies for lipid lowering treatment: PCSK9 inhibition

Speaker: Professor F. Mach (Geneva, CH)

Thumbnail

Anti-inflammatory therapy : interleukin-1 beta inhibition to prevent cardiovascular events

Speaker: Doctor P. Ridker (Boston, US)

Thumbnail

Balancing residual inflammatory, lipid, and thrombotic risk in coronary artery disease

Speaker: Professor P. Libby (Boston, US)

Thumbnail

Access the full session

Innovative strategies for secondary prevention

Speakers: Doctor T. Cuisset, Professor F. Mach, Doctor P. Ridker, Professor P. Libby
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb